Declining histone acetyltransferase GCN5 represses BMSC-mediated angiogenesis during osteoporosis.
Jing H, Liao L, Su X, Shuai Y, Zhang X, Deng Z, Jin Y.
Jing H, et al. Among authors: jin y.
FASEB J. 2017 Oct;31(10):4422-4433. doi: 10.1096/fj.201700118R. Epub 2017 Jun 22.
FASEB J. 2017.
PMID: 28642327
Our study results revealed an epigenetic mechanism controlling BMSC-mediated angiogenesis and provided a novel therapeutic target for osteoporosis treatment.-Jing, H., Liao, L., Su, X., Shuai, Y. Zhang, X., Deng, Z., Jin, Y. Declining histone acetyltransferas …
Our study results revealed an epigenetic mechanism controlling BMSC-mediated angiogenesis and provided a novel therapeutic target for osteop …